After this article was published, similarities were noted between this article and submissions by other research groups which call into question the validity and provenance of the reported results and the adherence of this article to the PLOS Authorship policy. The authors provided data files to support the article’s results, but the comments and files received did not resolve the concerns.
In discussing this matter, the corresponding author requested the article’s retraction.
In light of the above issues, the PLOS ONE Editors retract this article [1].
JC agreed with retraction. TT, QY, CZ, and XL did not respond or could not be reached.
Reference
- 1. Tian T, Yang Q, Zhang C, Li X, Cheng J (2021) MiRNA-107 enhances the malignant progression of pancreatic cancer by targeting TGFBR3. PLoS ONE 16(5): e0249375. https://doi.org/10.1371/journal.pone.0249375 pmid:34010341
Citation: The PLOS ONE Editors (2022) Retraction: MiRNA-107 enhances the malignant progression of pancreatic cancer by targeting TGFBR3. PLoS ONE 17(1): e0263037. https://doi.org/10.1371/journal.pone.0263037
Published: January 21, 2022
Copyright: © 2022 The PLOS ONE Editors. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.